PARG
PARG (poly(ADP-ribose) glycohydrolase) is the major enzyme that catabolises poly(ADP-ribose), a reversible covalent modifier of chromosomal proteins. By hydrolysing the ribose-ribose bonds in the polymer, it removes the signal laid down by poly(ADP-ribose) synthesis, notably after DNA damage. Browse Assay Genie's current range of PARG research reagents below, or read on for the biology behind the target.
PARG degrades poly(ADP-ribose) by hydrolysing the ribose-ribose bonds within the polymer. It acts mainly as an exo-glycohydrolase, though it can act as an endo-glycohydrolase at low efficiency, releasing poly(ADP-ribose) chains of different lengths as well as ADP-ribose monomers. It cannot cleave the ester bond between the terminal ADP-ribose and the modified residue, so proteins are left mono-ADP-ribosylated. This makes PARG responsible for the prevalence of mono-ADP-ribosylated proteins in cells.
Poly(ADP-ribose) made after DNA damage is present only transiently and is rapidly degraded by PARG. The enzyme is required to prevent harmful accumulation of poly(ADP-ribose) during prolonged replicative stress, although it is not needed for recovery from transient replicative stress. PARG is also required for retinoic acid-dependent gene transactivation, probably by removing poly(ADP-ribose) from the histone demethylase KDM4D and so allowing chromatin derepression at RAR-dependent promoters. Together with PARP1, NMNAT1 and NUDT5, it contributes to nuclear ATP synthesis, which supports energy-consuming chromatin remodelling.
The human PARG gene encodes a protein found in many tissues. According to the NCBI Gene summary, it may be subject to proteolysis that generates smaller, active products, and several transcript variants encode different isoforms. UniProt places the protein in the nucleus, cytoplasm and mitochondrial matrix, and assigns it to the poly(ADP-ribose) glycohydrolase family. Researchers studying PARG biology may look for a PARG antibody, a PARG ELISA kit or recombinant PARG protein, and the mouse and rat orthologues are both called Parg.
PARG rapidly degrades the poly(ADP-ribose) synthesised after DNA damage, so it is central to studying how this transient signal is resolved.
PARG prevents detrimental poly(ADP-ribose) accumulation during prolonged replicative stress, making it relevant to genome maintenance research.
PARG is needed for retinoic acid-dependent transactivation, probably by removing poly(ADP-ribose) from KDM4D to derepress RAR-dependent promoters.
PARG works with PARP1, NMNAT1 and NUDT5 in nuclear ATP synthesis, which fuels energy-consuming chromatin remodelling.
PARG is a glycohydrolase that breaks down poly(ADP-ribose) by hydrolysing its ribose-ribose bonds, releasing polymer fragments and ADP-ribose monomers. It cannot remove the terminal ADP-ribose from the protein, so substrates are left mono-ADP-ribosylated. This limits poly(ADP-ribose) accumulation after DNA damage.
The NCBI Gene summary reports that several transcript variants encode different isoforms of PARG. It also notes that the protein may be proteolysed into smaller, active products. The enzyme is found in many tissues and is annotated to the nucleus, cytoplasm and mitochondrion.
Mouse and rat both have a Parg orthologue of the human gene. The protein belongs to the poly(ADP-ribose) glycohydrolase family. For cross-species work, check the datasheet of any product for its validated reactivity.
Pathway partners of PARG in poly(ADP-ribose) turnover, nuclear ATP synthesis and chromatin regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86W56; product specifications from Assay Genie datasheets.